Skip to main content
    I

    IGC Pharma, Inc. (IGC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.19
    +0.01 (+7.43%)

    Market Cap: $20.42M

    Last updated: Nov 17, 2026 at 4:38 PM ET

    IGC Pharma, Inc. (IGC) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    IGC Pharma (IGC) has a latest price of $0.19 on Nov 17, 2026, 48.4% below its 52-week high of $0.36. Its price fell 52.2% over the past 12 months. The month-end price fell 55.7% over the 10 years through Oct 2026, a compound annual decline of 7.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $6.45 in Sep 2018 and its lowest $0.18 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart IGC with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IGC.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 27.6%, and over 6 months it fell 41.7%. The month-end price fell 38.3% over the 3 years through Oct 2026, a compound annual decline of 14.9%.

    PeriodChange
    1 month-33.6%
    3 months-27.6%
    6 months-41.7%
    12 months-52.2%
    12 months, with dividends-52.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-38.3%-14.9%
    5 years-86.8%-33.3%
    10 years-55.7%-7.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 257.1%, and its weakest was 2018, when it fell 72.0%.

    YearCloseChange
    2026 through Oct 2026$0.18-34.3%
    2025$0.28-16.3%
    2024$0.34+20.0%
    2023$0.28-11.9%
    2022$0.32-67.4%
    2021$0.98-37.4%
    2020$1.56+147.6%
    2019$0.63+125.0%
    2018$0.28-72.0%
    2017$1.00+257.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 24.4% below its 50-day average of $0.25 and 32.1% below its 200-day average of $0.27.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.19
    52-week high$0.36-48.4%
    52-week low$0.17+10.7%
    50-day average$0.25-24.4%
    200-day average$0.27-32.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 73.2%.

    MeasureValue
    1-year beta1.16
    Largest fall, 1 year-52.6%
    Largest fall, 3 years-73.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About IGC

    What is IGC's 1-year price change?

    IGC Pharma's price fell 52.2% over the past 12 months. With dividends included, the 12-month total return was -52.2%.

    What is IGC's 5-year price change?

    IGC Pharma's month-end price fell 86.8% over the 5 years through Oct 2026, a compound annual decline of 33.3%. These figures leave out dividends.

    What is IGC's 52-week high and low?

    IGC Pharma's 52-week high is $0.36 and its 52-week low is $0.17. Its latest price of $0.19 on Nov 17, 2026 is 48.4% below the high.

    What is IGC's beta?

    IGC Pharma's 1-year beta against the S&P 500 is 1.16, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 52.6%.

    Is the IGC chart free?

    Yes. Advanced Charting for IGC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.